Jeffery A. Lieberman

Statistics

Publications

Citations

1.2K

H-Index

Active since

1995

Affiliations

University of North Carolina at Chapel Hill(Current)

Columbia University

Duke University

University of Toronto

New York State Psychiatric Institute

Jeffery A. Lieberman is an author at University of North Carolina at Chapel Hill specializing in medicine, psychopharmacology, and antipsychotic pharmacotherapy.

Publications per year

1995–2021

Publications

A longitudinal study of neurocognitive function in individuals at-risk for psychosis

Richard S.E. Keefe, Diana O. Perkins, Hongbin Gu et al. · Schizophrenia Research · 2006 · 261 citations

Medicine, Neuroscience, Psychiatry +14

Olanzapine Versus Haloperidol Treatment in First-Episode Psychosis

T.M. Sanger, Jeffery A. Lieberman, Mauricio Tohen et al. · American Journal of Psychiatry · 1999 · 216 citations

Medicine, Pharmacotherapy, Psychiatry +17

National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer Disease Trial Methodology

Lon S. Schneider, Pierre N. Tariot, Constantine G. Lyketsos et al. · American Journal of Geriatric Psychiatry · 2001 · 210 citations

Medicine, Pharmacotherapy, Psychiatry +16

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation

Gary E. Duncan, Jeremy Leipzig, Richard B. Mailman et al. · Brain Research · 1998 · 123 citations

Medicine, Neuroscience, Pharmacology +14

Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine

Gary E. Duncan, Seiya Miyamoto, Jeremy Leipzig et al. · Brain Research · 1999 · 111 citations

Life Sciences, Neurobiology, Neuroscience +15

1–5 of 12